. Sensitivity, specificity, accuracy, PPV and NPV of POCUS relative to ileocolonoscopy POCUS in the detection of luminal inflammation compared to gold standard ileocolonscopy in patients presenting with undifferentiated lower gastrointestinal symptoms. Methods: A prospective, single-center study of consecutive patients presenting to the GI clinic with symptoms high risk for IBD were evaluated to differentiate IBD from IBS. POCUS was performed, clinical data recorded and C-reactive protein measured prior to ileocolonoscopy, which served as the gold standard. Sensitivity, specificity, positive predictive value and negative predictive value were calculated for POCUS. Results: Eighty-six patients with undifferentiated symptoms of diarrhea (76.7%), abdominal pain (62.8%) and weight loss (18.6%) were evaluated. Nocturnal symptoms (15.1%) and incontinence (11.6%) were infrequent (Table 1) . Ileocolonoscopy was negative in 72 patients confirming IBS, 2 patients had diverticulosis, while 12 revealed findings of active endoscopic disease consistent with IBD, confirmed on pathology, 11 with CD and 1 with UC, as well as microscopic colitis (N=8), diverticulosis (N=1), ischemic colitis (N=2) and one solitary rectal ulcer. The overall sensitivity, specificity, PPV and NPV of POCUS were 83.0%, 100%, 100%, and 97.37%, respectively. In cases where POCUS was positive, POCUS predicted the severity of inflammation as seen on ileocolonscopy accurately with correlate findings of 90% (9/10 cases accurately predicted severity). The accuracy of POCUS for predicting IBD was much better than CRP, as the sensitivity of CRP was only 37.5%, specificity 76.2%. Wait time for endoscopy for patients with a positive POCUS was shorter with a median of 3.5 weeks, compared to 4 weeks for those with a negative POCUS. Conclusions: Bedside POCUS is a useful triage tool, better than CRP in disease prediction, helpful to accurately detect the presence and severity of inflammation in the bowel and thus differentiate IBD from IBS. The detection of ileal disease was more accurate compared to colonic disease and future studies should be completed with addition of fecal calprotectin to optimize detection rates and overall accuracy.
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The early course of Crohn's disease: prognostic and treatment modalities during the first year of disease S. Raimundo Fernandes* 1 , L. Correia 1 , C. Baldaia 2 , P. Moura Santos 2 , A. Rita Gonçalves 2 , A. Valente 2 , J. Velosa 1 1 Hospital de Santa Maria, Serviço de Gastrenterologia e Hepatologia, Lisboa, Portugal; 2 Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal Background: Crohn's disease (CD) is a chronic immune-mediated disorder with a high risk for surgery. Although the natural history of CD has been extensively described in previous studies, the evolution during the first year after diagnosis has not be adequately described. The aim of this study was to Crohn's disease (CD) is a chronic immune-mediated disorder with a high risk for surgery. Although the natural history of CD has been extensively described in previous studies, the evolution during the first year after diagnosis has not be adequately described.
Methods: Retrospective analysis of a cohort of patients with an established diagnosis of CD from a tertiary referral center. Demographic and clinical data were retrieved and compared for prediction of outcomes across two time cohorts (before and after 2005). Results: 648 patients with CD, mean age 31.3±13.9 years, were included in this study. In the first year following diagnosis, 179 (27.6%) required therapy with thiopurines, 43 (6.6%) with an anti-TNF, and 147 (22.7%) underwent surgery. Patients with perianal disease were more likely to receive a thiopurine (OR 1.977 95% CI 1.370-2.852) or an anti-TNF (OR 2.190 95% CI 1.162-4.125) on the first year of disease, but not patients with younger age at diagnosis, stricturing/ penetrating behavior, and upper gastrointestinal disease. Smoking (OR 1.029 95% CI 1.012-1.046) and structuring/penetrating behavior (OR 9.556 95% CI 5.526-16.526), but not age at diagnosis, disease location or perianal disease were associated with the need for early surgery. Patients diagnosed before 2005 were less likely to receive thiopurine (12.9% versus 39.3%, p<0.001) or anti-TNF therapy (1.4% versus 10.4%, p<0.001). This fact could explain the fact that although patients diagnosed before and after 2005 showed similar rates of first surgery (25.0% versus 20.6%, p=0.110), a second surgery was less likely in patients diagnosed after 2005 (OR 0.172 95% CI 0.054-0.552, p=0.003). Conclusions: There is a high heterogeneity in the severity and management of patients with CD during the first year of disease. Early initiation of immunosuppressive therapy is associated with a lower incidence of postsurgical recurrence.
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Sporadic adenomas in IBD patients over 50 years old and average risk population -Is there a difference?
S. Monteiro* 1 , T. Cúrdia Gonçalves 1 , P. Boal Carvalho 1 , F. Dias de Castro 1 , S. Leite 1 , M.J. Moreira 1 , J. Cotter 1,2,3 1 Hospital da Senhora da Gastroenterology, Guimarães, Portugal; 2 University of Minho, School of Medicine, Braga, Portugal; 3 
University of Minho, Associate Laboratory ICVS/3B's, Braga, Portugal
Background: Adenoma is the major precursor of colorectal carcinoma (CRC) in general population. Patients with ulcerative colitis (UC) and Crohn's disease (CD) are at risk of developing CRC in relation to chronic inflammation. However, they can also develop adenomas, but the prevalence of sporadic adenomas in inflammatory bowel disease (IBD) patients is unknown. Methods: We performed a retrospective medical review of all colonoscopies performed in our center in IBD patients (UC ou CD) ≥50 or more years old between January 2008 and November 2016. The presence of colitis or proctitis was evaluated, as well as the use of IBD medication. The prevalence of SA in IBD patients were compared with averagerisk screening colonoscopy patients in a 3: 1 ratio over the same time period. The number and time intervals between colonoscopies were reviewed. For the prevalence calculation, we considered the first colonoscopy performed ≥50 years old.
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